Repository Corticotropic Injections Overview
Relapsed MS: The Role of Corticosteroids
The Goals of Relapsed MS First-Line Treatment
The Importance of Treating Relapsed MS
Future Directions in Treatment of MS Relapses
EDSS and Outcomes Measurement in MS
Systemic Steroids vs ACTH in Relapsing MS
ACTH: A Nonsystemic Steroid Alternative in Relapsing MS
Use of Repository Corticotropic Injections in MS Relapses
Use of Corticosteroids for MS Relapses
Algorithm for Treating MS Relapses
Making Purposeful Treatment Decisions for Meaningful Change
NeurologyLive Editor in Chief Stephen D. Silberstein, MD discusses the importance of reaching a treatment effect that makes a significant difference in patients' lives.
Fremanezumab Effective in Refractory Episodic and Chronic Migraine
Data from the phase 3b FOCUS trial demonstrates fremanezumab’s superior efficacy and tolerability in the prevention of migraine.
Rebecca Stainman, MD: Identifying, Addressing Physician Burnout
The child neurology resident at NYU Langone spoke about ways for residents to identify and address impaired colleagues that suffer from depression and burnout.
The Role of Marijuana in the Treatment of Neurologic Conditions
The professor of neurology at the Icahn School of Medicine at Mount Sinai discussed what still needs to be done to clarify medical marijuana’s position in medicine.
Unusual New Onset Seizures in a Healthy, Young Adult Male
A 23-year-old male college student presents with first generalized tonic-clonic seizure followed by episodes of violent psychosis.
Dementia Pathways Identified in Chronic Traumatic Encephalopathy
New findings have suggested dementia is a result of worsened white matter rarefaction, phosphorylated tau, and arteriolosclerosis due to repeated head trauma in former football players with CTE.
Parkinson DBS System Labels Approved For Use With Full-Body MRI
Boston Scientific’s Vercise Gevia deep brain stimulation system labels will allow for clinical use of stimulation during full-body MRI in patients with Parkinson disease, with an improved battery.
Future Management of Insomnia Disorder in Elderly Patients
Treating Insomnia in the Elderly: Orexin Receptor Antagonist
Insomnia in the Elderly: Selection of Pharmacologic Therapy
Wakefulness-Targeted Agents in Insomnia Management
Pharmacologic Therapy for Insomnia in the Elderly
Insomnia Management: Optimizing Nonpharmacologic Methods
Non-Pharmacologic Management of Insomnia in the Elderly
Consequences of Poor Sleep in the Elderly
Prevalence of Insomnia Disorder With Age
Defining and Diagnosing Insomnia Disorder
FDA Rejects Duchenne Muscular Dystrophy Drug Golodirsen, Citing Safety Concerns
The regulatory agency cited 2 concerns in the complete response letter: the risk of infections related to intravenous infusion ports and renal toxicity.
Addressing the Narcolepsy Diagnosis Delay
The director of the Sleep-Wake Disorders Center at Montefiore Medical Center will offer further insights on narcolepsy at the upcoming International Congress on the Future of Neurology, September 27-28, 2019 in New York City.
